Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia

Huijun Wang, Zhe Xu, Bo Hyun Lee, Simon Vu, Linghan Hu, Mingyang Lee, Dingfang Bu, Xu Cao, Samuel T Hwang, Yong Yang, Jie Zheng, Zhimiao Lin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Transient receptor potential (TRP) channels respond to various chemical and physical stimuli by mediating cation influx. The skin expresses abundant TRP channels of different subtypes, which play an essential role in the maintenance of skin functionality. Here, we report cases of mutations in TRPM4, which encodes TRPM4, a Ca 2+ -activated monovalent cation channel, as a cause of an autosomal dominant form of progressive symmetric erythrokeratodermia. In three separate families with progressive symmetric erythrokeratodermia, we identified two missense mutations (c.3099C>G and c.3119T>C) that produce p.Ile1033Met and p.Ile1040Thr, both of which are located in the S6 transmembrane domain of the TRPM4 protein. The substitutions are expected to directly affect activation gating of TRPM4 according to the cryo-EM structures. Electrophysiological studies of the mutants showed substantial hyperactivity, as evidenced by pronounced baseline activity, enhanced sensitivity to intracellular Ca 2+ , and an elevated resting membrane potential. In vitro studies showed enhanced proliferation in keratinocytes overexpressing either of the mutants. We also detected an up-regulation of markers for proliferation and differentiation of keratinocytes in the affected skin tissues. Our study identified TRPM4 as an important player in the pathogenesis of skin TRP channelopathies and a potential target for treatment of skin hyperkeratotic disorders.

Original languageEnglish (US)
JournalJournal of Investigative Dermatology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Erythrokeratodermia Variabilis
Skin
Chemical activation
Mutation
Transient Receptor Potential Channels
Keratinocytes
Channelopathies
S 6
Monovalent Cations
Differentiation Antigens
Missense Mutation
Membrane Potentials
Cations
Substitution reactions
Up-Regulation
Maintenance
Tissue
Membranes

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia. / Wang, Huijun; Xu, Zhe; Lee, Bo Hyun; Vu, Simon; Hu, Linghan; Lee, Mingyang; Bu, Dingfang; Cao, Xu; Hwang, Samuel T; Yang, Yong; Zheng, Jie; Lin, Zhimiao.

In: Journal of Investigative Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Wang, Huijun ; Xu, Zhe ; Lee, Bo Hyun ; Vu, Simon ; Hu, Linghan ; Lee, Mingyang ; Bu, Dingfang ; Cao, Xu ; Hwang, Samuel T ; Yang, Yong ; Zheng, Jie ; Lin, Zhimiao. / Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia. In: Journal of Investigative Dermatology. 2019.
@article{b1b315df9e6246fca4bd2a1ab0620306,
title = "Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia",
abstract = "Transient receptor potential (TRP) channels respond to various chemical and physical stimuli by mediating cation influx. The skin expresses abundant TRP channels of different subtypes, which play an essential role in the maintenance of skin functionality. Here, we report cases of mutations in TRPM4, which encodes TRPM4, a Ca 2+ -activated monovalent cation channel, as a cause of an autosomal dominant form of progressive symmetric erythrokeratodermia. In three separate families with progressive symmetric erythrokeratodermia, we identified two missense mutations (c.3099C>G and c.3119T>C) that produce p.Ile1033Met and p.Ile1040Thr, both of which are located in the S6 transmembrane domain of the TRPM4 protein. The substitutions are expected to directly affect activation gating of TRPM4 according to the cryo-EM structures. Electrophysiological studies of the mutants showed substantial hyperactivity, as evidenced by pronounced baseline activity, enhanced sensitivity to intracellular Ca 2+ , and an elevated resting membrane potential. In vitro studies showed enhanced proliferation in keratinocytes overexpressing either of the mutants. We also detected an up-regulation of markers for proliferation and differentiation of keratinocytes in the affected skin tissues. Our study identified TRPM4 as an important player in the pathogenesis of skin TRP channelopathies and a potential target for treatment of skin hyperkeratotic disorders.",
author = "Huijun Wang and Zhe Xu and Lee, {Bo Hyun} and Simon Vu and Linghan Hu and Mingyang Lee and Dingfang Bu and Xu Cao and Hwang, {Samuel T} and Yong Yang and Jie Zheng and Zhimiao Lin",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jid.2018.10.044",
language = "English (US)",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Gain-of-Function Mutations in TRPM4 Activation Gate Cause Progressive Symmetric Erythrokeratodermia

AU - Wang, Huijun

AU - Xu, Zhe

AU - Lee, Bo Hyun

AU - Vu, Simon

AU - Hu, Linghan

AU - Lee, Mingyang

AU - Bu, Dingfang

AU - Cao, Xu

AU - Hwang, Samuel T

AU - Yang, Yong

AU - Zheng, Jie

AU - Lin, Zhimiao

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Transient receptor potential (TRP) channels respond to various chemical and physical stimuli by mediating cation influx. The skin expresses abundant TRP channels of different subtypes, which play an essential role in the maintenance of skin functionality. Here, we report cases of mutations in TRPM4, which encodes TRPM4, a Ca 2+ -activated monovalent cation channel, as a cause of an autosomal dominant form of progressive symmetric erythrokeratodermia. In three separate families with progressive symmetric erythrokeratodermia, we identified two missense mutations (c.3099C>G and c.3119T>C) that produce p.Ile1033Met and p.Ile1040Thr, both of which are located in the S6 transmembrane domain of the TRPM4 protein. The substitutions are expected to directly affect activation gating of TRPM4 according to the cryo-EM structures. Electrophysiological studies of the mutants showed substantial hyperactivity, as evidenced by pronounced baseline activity, enhanced sensitivity to intracellular Ca 2+ , and an elevated resting membrane potential. In vitro studies showed enhanced proliferation in keratinocytes overexpressing either of the mutants. We also detected an up-regulation of markers for proliferation and differentiation of keratinocytes in the affected skin tissues. Our study identified TRPM4 as an important player in the pathogenesis of skin TRP channelopathies and a potential target for treatment of skin hyperkeratotic disorders.

AB - Transient receptor potential (TRP) channels respond to various chemical and physical stimuli by mediating cation influx. The skin expresses abundant TRP channels of different subtypes, which play an essential role in the maintenance of skin functionality. Here, we report cases of mutations in TRPM4, which encodes TRPM4, a Ca 2+ -activated monovalent cation channel, as a cause of an autosomal dominant form of progressive symmetric erythrokeratodermia. In three separate families with progressive symmetric erythrokeratodermia, we identified two missense mutations (c.3099C>G and c.3119T>C) that produce p.Ile1033Met and p.Ile1040Thr, both of which are located in the S6 transmembrane domain of the TRPM4 protein. The substitutions are expected to directly affect activation gating of TRPM4 according to the cryo-EM structures. Electrophysiological studies of the mutants showed substantial hyperactivity, as evidenced by pronounced baseline activity, enhanced sensitivity to intracellular Ca 2+ , and an elevated resting membrane potential. In vitro studies showed enhanced proliferation in keratinocytes overexpressing either of the mutants. We also detected an up-regulation of markers for proliferation and differentiation of keratinocytes in the affected skin tissues. Our study identified TRPM4 as an important player in the pathogenesis of skin TRP channelopathies and a potential target for treatment of skin hyperkeratotic disorders.

UR - http://www.scopus.com/inward/record.url?scp=85061567021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061567021&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2018.10.044

DO - 10.1016/j.jid.2018.10.044

M3 - Article

C2 - 30528822

AN - SCOPUS:85061567021

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

ER -